Abstract:OBJECTIVE Gliclazide is one of the most widely used therapeutic drugs for diabetes. As a second-generation sulfonylurea oral hypoglycemic drug, it can lower blood glucose level and delay the occurrence and development of diabetic nephropathy (DN). However, the underlying mechanism remains unclear. Therefore, the aim of this study was to explore whether gliclazide had protective effects on high glucose and advanced glycation end products (AGEs)-induced injury of human mesangial cells (HMCs) and renal tubular epithelial cells. MATERIALS AND METHODS HMC and renal tubular epithelial cell lines [human kidney 2 (HK-2)] were cultured in vitro. All cells were then divided into the follow groups: 1) blank control group (5.6 mmol/L glucose), 2) AGEs group [400 μg/mL AGE-bovine serum albumin (AGE-BSA)], 3) high glucose group (25 mmol/L glucose), 4) gliclazide + AGEs group (400 μg/mL AGE-BSA + 20 μmol/L gliclazide) and 5) gliclazide + high glucose group (25 mmol/L glucose + 20 μmol/L gliclazide). Cell counting kit-8 (CCK-8) assay was adopted to determine cell viability. Flow cytometry was used to detect cell apoptosis. The levels of malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were measured as well. Furthermore, the mRNA expressions of receptor for AGE (RAGE), p22phox and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) were measured via fluorescence quantitative Real-time polymerase chain reaction (qRT-PCR). RESULTS Compared with control group, significantly accelerated apoptosis of HMCs and HK-2, increased MDA level, decreased SOD and GSH-Px levels, and up-regulated mRNA expressions of RAGE, p22phox and NF-κB were observed in HMCs and HK-2 of high glucose group and AGEs group. Meanwhile, there were obviously alleviated apoptosis of HMCs and HK-2, decreased MDA level, increased SOD and GSH-Px levels, as well as down-regulated mRNA expressions of RAGE, p22phox and NF-κB in HMCs and HK-2 of gliclazide group compared with high glucose and AGEs group. Furthermore, significant correlations were found between the mRNA expression of RAGE and the apoptosis rate of HMCs and HK-2 (HMCs: r=0.701, p=0.004 and HK-2: r=0.633, p=0.011). CONCLUSIONS Gliclazide has protective effects on high glucose and AGEs-induced damage of glomerular mesangial cells and renal tubular epithelial cells via inhibiting RAGE-NADPH oxidase-NF-kB pathway.

Pentagalloylglucose Reduces AGE-induced Inflammation by Activating Nrf2/HO-1 and Inhibiting the JAK2/STAT3 Pathway in Mesangial Cells.

Rosiglitazone Via Upregulation of Akt/Enos Pathways Attenuates Dysfunction of Endothelial Progenitor Cells, Induced by Advanced Glycation End Products

Polydatin Promotes Nrf2-ARE Anti-Oxidative Pathway Through Activating Sirt1 to Resist AGEs-induced Upregulation of Fibronetin and Transforming Growth Factor-Β1 in Rat Glomerular Messangial Cells.

Polydatin Attenuates AGEs-induced Upregulation of Fibronectin and ICAM-1 in Rat Glomerular Mesangial Cells and Db/db Diabetic Mice Kidneys by Inhibiting the Activation of the SphK1-S1P Signaling Pathway

Peperomia pellucida (L.) Kunth suppresses glycation-induced inflammatory response in human retinal pigment epithelial cell line ARPE-19 via JAK-STAT3 signaling

Paeoniflorin Ameliorates Ages-Induced Mesangial Cell Injury Through Inhibiting Rage/Mtor/Autophagy Pathway

Pentagalloyl glucose induces anti-inflammatory macrophage polarization - suppressing macrophage mediated vascular cell dysfunction and TGF-β secretion

Inhibition of Inflammatory Factors by Parthenolide in Human Renal Mesangial Cells under Hyperglycemic Condition

DJC Suppresses Advanced Glycation End Products-Induced JAK-STAT Signaling and ROS in Mesangial Cells

Effects of PPAR-γ activation on the expressions of TGF-β and CTGF mRNA in rat mesangial cells induced by advanced glycation end products

Antioxidative and Anti-Inflammatory Activities of Paeoniflorin and Oxypaeoniflora on AGEs-induced Mesangial Cell Damage.

Grape Seed Proanthocyanidins Ameliorate Diabetic Nephropathy Via Modulation of Levels of AGE, RAGE and CTGF.

Pentosan Polysulfate Ameliorates Fibrosis and Inflammation Markers in SV40 MES13 Cells by Suppressing Activation of PI3K/AKT Pathway Via Mir-446A-3p.

Effects of PPAR-γ Activation on Rat Mesangial Cell Extracellular Matrix Accumulation Induced by Advanced Glycation End Products

Protective Effects of Kaempferitrin on Advanced Glycation End Products Induce Mesangial Cell Apoptosis and Oxidative Stress

Ganoderic Acid A Inhibits High Glucose-Induced Oxidative Stress and Extracellular Matrix Accumulation in Rat Glomerular Mesangial Cells

Pioglitazone inhibits advanced glycation end product-induced TNF-α and MMP-13 expression via the antagonism of NF-κB activation in chondrocytes.

Protective Effects of Gliclazide on High Glucose and AGEs-induced Damage of Glomerular Mesangial Cells and Renal Tubular Epithelial Cells Via Inhibiting RAGE-p22phox-NF-kB Pathway.

Inhibition Of Reactive Oxygen Species/Extracellular Signal-Regulated Kinases Pathway By Pioglitazone Attenuates Advanced Glycation End Products-Induced Proliferation Of Vascular Smooth Muscle Cells In Rats

The Hydrolyzable Gallotannin, Penta-O-galloyl-β-d-glucopyranoside, Inhibits the Formation of Advanced Glycation Endproducts by Protecting Protein Structure

The Role of PPARγ in Advanced Glycation End Products-Induced Inflammatory Response in Human Chondrocytes.